Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of Naturlose (Tagatose) on Glycemic Control and Safety of Naturlose Over One Year in Subjects With Type 2 Diabetes Under Diet Control and Exercise

NCT00955747 is registered in ClinicalTrials.gov with Robert Lodder as lead sponsor.

NCT NCT00955747
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00955747 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of Naturlose (Tagatose) on Glycemic Control and Safety of Naturlose Over One Year in Subjects With Type 2 Diabetes Under Diet Control and Exercise
Lead sponsor
Robert Lodder
Phase
Phase 3
Overall status
Completed
Start date
April 30, 2007
Completion date
October 31, 2010
Enrollment
494 (actual)
Sites
46

Conditions

As the registry lists them; a condition with its own page is linked.

type 2 diabetes